- Home
- PTA vs CRON Comparison
PTA vs CRON Comparison
Compare PTA & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTA | CRON |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | PTA | CRON |
|---|---|---|
| Price | $18.96 | $2.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 116.3K | ★ 1.0M |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | ★ 8.31% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $146,587,000.00 |
| Revenue This Year | N/A | $32.15 |
| Revenue Next Year | N/A | $10.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 24.63 |
| 52 Week Low | $17.40 | $1.60 |
| 52 Week High | $20.92 | $3.43 |
Technical Indicators
Market Signals| Indicator | PTA | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 25.33 | 40.56 |
| Support Level | $18.87 | $2.44 |
| Resistance Level | $19.68 | $2.77 |
| Average True Range (ATR) | 0.18 | 0.08 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 2.15 | 11.29 |
Price Performance
Historical ComparisonAbout PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its main investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.
About CRON Cronos Group Inc.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.